{"count": 28, "results": [{"_id": "34881181", "pmid": 34881181, "pmcid": "PMC8645640", "title": "Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway", "journal": "Front Oncol", "authors": ["Lu Y", "Xin D", "Guan L", "Xu M", "Yang Y", "Chen Y", "Yang Y", "Wang-Gillam A", "Wang L", "Zong S", "Wang F"], "date": "2021-11-22T00:00:00Z", "doi": "10.3389/fonc.2021.762523", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "", "meta_pages": "762523", "score": 50276.01, "text_hl": "To characterize the mechanism by which @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibits @GENE_CD274 @GENE_29126 @@@PD-L1@@@ expression in @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinoma@@@ (@<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@) and to evaluate the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the antitumor immune response.", "citations": {"NLM": "Lu Y, Xin D, Guan L, Xu M, Yang Y, Chen Y, Yang Y, Wang-Gillam A, Wang L, Zong S, Wang F. Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway Front Oncol. 2021;11():762523. PMID: 34881181", "BibTeX": "@article{34881181, title={Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway}, author={Lu Y and Xin D and Guan L and Xu M and Yang Y and Chen Y and Yang Y and Wang-Gillam A and Wang L and Zong S and Wang F}, journal={Front Oncol}, volume={11}, pages={762523}}"}}, {"_id": "33485367", "pmid": 33485367, "pmcid": "PMC7825246", "title": "Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10", "journal": "J Exp Clin Cancer Res", "authors": ["Chen F", "Xu B", "Li J", "Yang X", "Gu J", "Yao X", "Sun X"], "date": "2021-01-23T00:00:00Z", "doi": "10.1186/s13046-021-01834-9", "meta_date_publication": "2021 Jan 23", "meta_volume": "40", "meta_issue": "1", "meta_pages": "38", "score": 50275.1, "text_hl": "Therefore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could be further investigated as a therapeutic option for the treatment of @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@OSCC@@@.", "citations": {"NLM": "Chen F, Xu B, Li J, Yang X, Gu J, Yao X, Sun X. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10 J Exp Clin Cancer Res. 2021 Jan 23;40(1):38. PMID: 33485367", "BibTeX": "@article{33485367, title={Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10}, author={Chen F and Xu B and Li J and Yang X and Gu J and Yao X and Sun X}, journal={J Exp Clin Cancer Res}, volume={40}, number={1}, pages={38}}"}}, {"_id": "32274150", "pmid": 32274150, "pmcid": "PMC7138989", "title": "Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study", "journal": "J Thorac Dis", "authors": ["He HH", "Fu JH", "Hao ZX", "Wu HF", "Zhong Q", "Wang F", "Liu HH", "Gu XS", "Wang B", "Huang HD", "Li ZY", "He JX"], "date": "2020-03-01T00:00:00Z", "doi": "10.21037/jtd.2019.12.98", "meta_date_publication": "2020 Mar", "meta_volume": "12", "meta_issue": "3", "meta_pages": "830-838", "score": 50263.51, "text_hl": "Impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on survival outcome of @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinomas@@@ @SPECIES_9606 @@@patients@@@ undergoing surgical resection: a multicenter retrospective study", "citations": {"NLM": "He HH, Fu JH, Hao ZX, Wu HF, Zhong Q, Wang F, Liu HH, Gu XS, Wang B, Huang HD, Li ZY, He JX. Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study J Thorac Dis. 2020 Mar;12(3):830-838. PMID: 32274150", "BibTeX": "@article{32274150, title={Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study}, author={He HH and Fu JH and Hao ZX and Wu HF and Zhong Q and Wang F and Liu HH and Gu XS and Wang B and Huang HD and Li ZY and He JX}, journal={J Thorac Dis}, volume={12}, number={3}, pages={830-838}}"}}, {"_id": "31821177", "pmid": 31821177, "title": "Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.", "journal": "Am J Gastroenterol", "authors": ["Wang QL", "Santoni G", "Ness-Jensen E", "Lagergren J", "Xie SH"], "date": "2020-01-01T00:00:00Z", "doi": "10.14309/ajg.0000000000000478", "meta_date_publication": "2020 Jan", "meta_volume": "115", "meta_issue": "1", "meta_pages": "73-78", "score": 50263.31, "text_hl": "Association Between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use and Risk of @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@Esophageal Squamous Cell Carcinoma@@@ in a Population-Based Cohort Study.", "citations": {"NLM": "Wang QL, Santoni G, Ness-Jensen E, Lagergren J, Xie SH. Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study. Am J Gastroenterol. 2020 Jan;115(1):73-78. PMID: 31821177", "BibTeX": "@article{31821177, title={Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.}, author={Wang QL and Santoni G and Ness-Jensen E and Lagergren J and Xie SH}, journal={Am J Gastroenterol}, volume={115}, number={1}, pages={73-78}}"}}, {"_id": "35134807", "pmid": 35134807, "title": "Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.", "journal": "Oncology", "authors": ["Sekino N", "Kano M", "Kobayashi S", "Murakami K", "Sakata H", "Toyozumi T", "Endo S", "Matsumoto Y", "Suito H", "Takahashi M", "Otsuka R", "Yokoyama M", "Shiraishi T", "Okada K", "Kamata T", "Ryuzaki T", "Hirasawa S", "Kinoshita K", "Sasaki T", "Iida K", "Komatsu A", "Matsubara H"], "date": "2022-01-01T00:00:00Z", "doi": "10.1159/000522446", "meta_date_publication": "2022", "meta_volume": "100", "meta_issue": "5", "meta_pages": "267-277", "score": 50261.1, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@Esophageal Squamous Cell Carcinoma@@@.", "citations": {"NLM": "Sekino N, Kano M, Kobayashi S, Murakami K, Sakata H, Toyozumi T, Endo S, Matsumoto Y, Suito H, Takahashi M, Otsuka R, Yokoyama M, Shiraishi T, Okada K, Kamata T, Ryuzaki T, Hirasawa S, Kinoshita K, Sasaki T, Iida K, Komatsu A, Matsubara H. Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma. Oncology. 2022;100(5):267-277. PMID: 35134807", "BibTeX": "@article{35134807, title={Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.}, author={Sekino N and Kano M and Kobayashi S and Murakami K and Sakata H and Toyozumi T and Endo S and Matsumoto Y and Suito H and Takahashi M and Otsuka R and Yokoyama M and Shiraishi T and Okada K and Kamata T and Ryuzaki T and Hirasawa S and Kinoshita K and Sasaki T and Iida K and Komatsu A and Matsubara H}, journal={Oncology}, volume={100}, number={5}, pages={267-277}}"}}, {"_id": "32646922", "pmid": 32646922, "title": "Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.", "journal": "Clin Cancer Res", "authors": ["Wang S", "Lin Y", "Xiong X", "Wang L", "Guo Y", "Chen Y", "Chen S", "Wang G", "Lin P", "Chen H", "Yeung SJ", "Bremer E", "Zhang H"], "date": "2020-09-15T00:00:00Z", "doi": "10.1158/1078-0432.CCR-20-0113", "meta_date_publication": "2020 Sep 15", "meta_volume": "26", "meta_issue": "18", "meta_pages": "4921-4932", "score": 50259.547, "text_hl": "The antidiabetic agent @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may influence anticancer immunity in @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinoma@@@ (@<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@). ", "citations": {"NLM": "Wang S, Lin Y, Xiong X, Wang L, Guo Y, Chen Y, Chen S, Wang G, Lin P, Chen H, Yeung SJ, Bremer E, Zhang H. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clin Cancer Res. 2020 Sep 15;26(18):4921-4932. PMID: 32646922", "BibTeX": "@article{32646922, title={Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.}, author={Wang S and Lin Y and Xiong X and Wang L and Guo Y and Chen Y and Chen S and Wang G and Lin P and Chen H and Yeung SJ and Bremer E and Zhang H}, journal={Clin Cancer Res}, volume={26}, number={18}, pages={4921-4932}}"}}, {"_id": "33603170", "pmid": 33603170, "pmcid": "PMC7979537", "title": "Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling", "journal": "Oncogene", "authors": ["Wang L", "Du L", "Xiong X", "Lin Y", "Zhu J", "Yao Z", "Wang S", "Guo Y", "Chen Y", "Geary K", "Pan Y", "Zhou F", "Gao S", "Zhang D", "Yeung SJ", "Zhang H"], "date": "2021-03-01T00:00:00Z", "doi": "10.1038/s41388-021-01682-z", "meta_date_publication": "2021 Mar", "meta_volume": "40", "meta_issue": "11", "meta_pages": "1974-1987", "score": 50254.676, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ downregulates @GENE_CHRNA7 @GENE_1139 @@@CHRNA7@@@ by enhancing its promoter DNA hypermethylation to repress @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@ @DISEASE_Neoplasms_Basal_Cell @DISEASE_MESH:D018295 @@@CIC@@@ properties.", "citations": {"NLM": "Wang L, Du L, Xiong X, Lin Y, Zhu J, Yao Z, Wang S, Guo Y, Chen Y, Geary K, Pan Y, Zhou F, Gao S, Zhang D, Yeung SJ, Zhang H. Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling Oncogene. 2021 Mar;40(11):1974-1987. PMID: 33603170", "BibTeX": "@article{33603170, title={Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling}, author={Wang L and Du L and Xiong X and Lin Y and Zhu J and Yao Z and Wang S and Guo Y and Chen Y and Geary K and Pan Y and Zhou F and Gao S and Zhang D and Yeung SJ and Zhang H}, journal={Oncogene}, volume={40}, number={11}, pages={1974-1987}}"}}, {"_id": "35036355", "pmid": 35036355, "pmcid": "PMC8753059", "title": "Erratum: Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway", "journal": "Front Oncol", "authors": ["Frontiers Production Office"], "date": "2021-12-29T00:00:00Z", "doi": "10.3389/fonc.2021.832786", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "", "meta_pages": "832786", "score": 50252.727, "text_hl": "Erratum: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Downregulates @GENE_CD274 @GENE_29126 @@@PD-L1@@@ Expression in @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@Esophageal Squamous Cell Carcinoma@@@ by Inhibiting @GENE_IL6 @GENE_3569 @@@IL-6@@@ Signaling Pathway", "citations": {"NLM": "Frontiers Production Office. Erratum: Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway Front Oncol. 2021;11():832786. PMID: 35036355", "BibTeX": "@article{35036355, title={Erratum: Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway}, author={Frontiers Production Office}, journal={Front Oncol}, volume={11}, pages={832786}}"}}, {"_id": "35738180", "pmid": 35738180, "title": "Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.", "journal": "Biomed Pharmacother", "authors": ["Wang Z", "Wang J", "Zhao H", "Zhao T", "Chen Y", "Jiang M", "Zhang S", "Wei Y", "Zhang J", "Zhou Y", "Shi S", "Fu Z", "Yang Y", "Zhang Y", "Yang L", "Que J", "Liu K"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.biopha.2022.113309", "meta_date_publication": "2022 Sep", "meta_volume": "153", "meta_issue": "", "meta_pages": "113309", "score": 50248.93, "text_hl": "Additionally, @CHEMICAL_3_aminobenzamide @CHEMICAL_MESH:C025160 @@@3-ABA@@@ synergistically suppressed the growth of @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@ cells when combined with @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ potentiated the suppressive effect of @CHEMICAL_3_aminobenzamide @CHEMICAL_MESH:C025160 @@@3-ABA@@@ on @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@ESCC@@@ cell growth. ", "citations": {"NLM": "Wang Z, Wang J, Zhao H, Zhao T, Chen Y, Jiang M, Zhang S, Wei Y, Zhang J, Zhou Y, Shi S, Fu Z, Yang Y, Zhang Y, Yang L, Que J, Liu K. Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma. Biomed Pharmacother. 2022 Sep;153():113309. PMID: 35738180", "BibTeX": "@article{35738180, title={Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.}, author={Wang Z and Wang J and Zhao H and Zhao T and Chen Y and Jiang M and Zhang S and Wei Y and Zhang J and Zhou Y and Shi S and Fu Z and Yang Y and Zhang Y and Yang L and Que J and Liu K}, journal={Biomed Pharmacother}, volume={153}, pages={113309}}"}}, {"_id": "24886082", "pmid": 24886082, "pmcid": "PMC4020916", "title": "Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)", "journal": "BMC Cancer", "authors": ["Damelin LH", "Jivan R", "Veale RB", "Rousseau AL", "Mavri-Damelin D"], "date": "2014-05-05T00:00:00Z", "doi": "10.1186/1471-2407-14-314", "meta_date_publication": "2014 May 5", "meta_volume": "14", "meta_issue": "", "meta_pages": "314", "score": 50091.74, "text_hl": "Anti-proliferative effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Esophageal_Squamous_Cell_Carcinoma</m> @DISEASE_MESH:D000077277 @@@OSCC@@@ cells. ", "citations": {"NLM": "Damelin LH, Jivan R, Veale RB, Rousseau AL, Mavri-Damelin D. Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones) BMC Cancer. 2014 May 5;14():314. PMID: 24886082", "BibTeX": "@article{24886082, title={Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)}, author={Damelin LH and Jivan R and Veale RB and Rousseau AL and Mavri-Damelin D}, journal={BMC Cancer}, volume={14}, pages={314}}"}}]}